Dr. Gopal Venkatesan

As Chief Executive Officer, Gopal leads the science behind BioFutureRx's programs. He brings a rigorous technical lens to the company's peptide-design work, guiding the molecular engineering that gives BFRx3711 its extended half-life and receptor profile.

His work spans the full arc of a development-stage asset — directing preclinical research, shaping the development plan, and mapping the regulatory pathway toward IND and beyond. That breadth lets him steer not only the chemistry, but the strategy that turns a promising molecule into a credible clinical candidate.

Across the pipeline, Gopal is the link between the bench and the boardroom, ensuring BioFutureRx's programs rest on a sound scientific and regulatory foundation.